Literature DB >> 29776917

Treatment-Refractory Mania with Psychosis in a Post-Transplant Patient on Tacrolimus: A Case Report.

Muaid Ithman1, Kunal Malhotra2, Meelie Bordoloi1, Garima Singh1.   

Abstract

Bipolar affective disorder type I imparts significant morbidity and disease burden in the population. It is characterized by occurrence of one or more manic episodes which may be preceded or followed by a depressive or hypomanic phase. About half of these manic episodes are characterized by the presence of psychotic features. The condition is further complicated when the patient has multiple comorbid conditions. We report here the case of a Caucasian woman, aged 66 years, previously diagnosed with Bipolar disorder who developed treatment refractory mania with psychotic feature after being on the immunosuppressive agent, tacrolimus, after kidney transplantation.
© 2018 Marshfield Clinic.

Entities:  

Keywords:  Bipolar affective disorder; Psychosis; Renal transplant; Tacrolimus; Treatment resistance

Mesh:

Substances:

Year:  2018        PMID: 29776917      PMCID: PMC6108512          DOI: 10.3121/cmr.2018.1409

Source DB:  PubMed          Journal:  Clin Med Res        ISSN: 1539-4182


  12 in total

1.  Catatonia as a manifestation of tacrolimus-induced neurotoxicity in organ transplant patients: a case series.

Authors:  Amit Chopra; Piyush Das; Abhishek Rai; Preetha Sharone Kuppuswamy; Xiofan Li; John Huston; Kemuel Philbrick; Christopher Sola
Journal:  Gen Hosp Psychiatry       Date:  2011-09-19       Impact factor: 3.238

2.  Tacrolimus-induced neurotoxicity in kidney transplant recipients.

Authors:  P Veroux; M Veroux; C Puliatti; W Morale; D Cappello; M Valvo; M Macarone
Journal:  Transplant Proc       Date:  2002-12       Impact factor: 1.066

3.  Psychosis associated with elevated trough tacrolimus blood concentrations after combined kidney-pancreas transplant.

Authors:  E Corruble; C Buhl; D Esposito; J P Schuster; V A Chouinard; P Hardy; G Chouinard
Journal:  Int J Neuropsychopharmacol       Date:  2005-11-29       Impact factor: 5.176

4.  Managing psychosis in a renal transplant recipient with bipolar affective disorder and allograft rejection.

Authors:  Vatsa Dave; William Mulley; John Kanellis; Shaun Summers
Journal:  Nephrology (Carlton)       Date:  2015-03       Impact factor: 2.506

Review 5.  Neurotoxicity of calcineurin inhibitors: impact and clinical management.

Authors:  W O Bechstein
Journal:  Transpl Int       Date:  2000       Impact factor: 3.782

Review 6.  Therapeutic drug monitoring for immunosuppressants.

Authors:  S H Wong
Journal:  Clin Chim Acta       Date:  2001-11       Impact factor: 3.786

7.  The significance of psychotic features in manic episodes: a report from the NIMH collaborative study.

Authors:  W Coryell; A C Leon; C Turvey; H S Akiskal; T Mueller; J Endicott
Journal:  J Affect Disord       Date:  2001-12       Impact factor: 4.839

8.  Antipsychotics affect multiple calcium calmodulin dependent proteins.

Authors:  W J Rushlow; C Seah; L P Sutton; A Bjelica; N Rajakumar
Journal:  Neuroscience       Date:  2009-03-13       Impact factor: 3.590

Review 9.  Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature.

Authors:  Benjamin I Goldstein; David E Kemp; Joanna K Soczynska; Roger S McIntyre
Journal:  J Clin Psychiatry       Date:  2009-06-02       Impact factor: 4.384

10.  Tacrolimus-induced paranoid delusions and fugue-like state.

Authors:  Nithin Krishna; Joshua Chiappelli; Bernard A Fischer; Stephanie Knight
Journal:  Gen Hosp Psychiatry       Date:  2012-09-05       Impact factor: 3.238

View more
  2 in total

1.  New-onset Psychosis in an Immunosuppressed Patient With Kidney Transplantation: An Educational Case Report.

Authors:  Benjamin Mappin-Kasirer; Lawrence Hoffman; Shaifali Sandal
Journal:  Can J Kidney Health Dis       Date:  2020-08-04

2.  Tacrolimus-induced mania in a patient with nephrotic syndrome.

Authors:  Alok Kumar; Dorchhom Khrime; Vivek Ruhela
Journal:  Indian J Pharmacol       Date:  2020 Nov-Dec       Impact factor: 1.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.